Highlights and Quick Summary
- EPS (Basic) for the quarter ending March 31, 2023 was -0.1 (a -9.09% decrease compared to previous quarter)
- Year-over-year quarterly EPS (Basic) increased by 11.11%
- Annual EPS (Basic) for 2022 was 0.14 (a -129.79% decrease from previous year)
- Annual EPS (Basic) for 2021 was -0.47 (a -53.92% decrease from previous year)
- Annual EPS (Basic) for 2020 was -1.02 (a -51.2% decrease from previous year)
- Twelve month EPS (Basic) ending March 31, 2023 was 0.14 (a 0.0% decrease compared to previous quarter)
- Twelve month trailing EPS (Basic) decreased by -129.79% year-over-year
Trailing EPS (Basic) for the last four month:
| 31 Mar '23 | 31 Dec '22 | 30 Sep '22 | 30 Jun '22 |
|---|---|---|---|
| 0.14 | 0.14 | 0.12 | -0.47 |
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EPS (Basic) of Precigen, Inc.
Most recent EPS (Basic)of PGEN including historical data for past 10 years.Interactive Chart of EPS (Basic) of Precigen, Inc.
Precigen, Inc. EPS (Basic) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | -0.1 | – | – | – | – |
| 2022 | -0.11 | 0.44 | -0.09 | -0.1 | 0.14 |
| 2021 | -0.13 | -0.15 | -0.1 | -0.09 | -0.47 |
| 2020 | -0.23 | -0.18 | -0.26 | -0.35 | -1.02 |
| 2019 | -1.09 | -0.35 | -0.25 | -0.4 | -2.09 |
| 2018 | -2.59 | -0.44 | -0.51 | -0.33 | -3.93 |
| 2017 | -0.23 | -0.33 | -0.16 | -0.26 | -0.98 |
| 2016 | -0.37 | -0.24 | -0.42 | -0.55 | -1.58 |
| 2015 | -0.28 | -0.34 | -0.37 | 0.26 | -0.76 |
| 2014 | 0.19 | -0.53 | -0.53 | 0.04 | -0.83 |
| 2013 | -0.13 | 0.15 | -0.17 | -0.48 | -1.4 |
| 2012 | – | – | – | – | -1.17 |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology